Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
赖氨肌醇维生素B12口服溶液 (Lysine Inositol Vitamin B12 Oral Solution) is a compound oral solution containing lysine hydrochloride, inositol, and vitamin B12 (cyanocobalamin). It is primarily developed and manufactured by Zhejiang Deyer Pharmaceutical and other manufacturers in China. Lysine is an essential amino acid that promotes growth, development, and nitrogen balance; inositol supports hepatic fat metabolism; and vitamin B12 acts as a key coenzyme for DNA synthesis and red blood cell formation. Together, these components act synergistically to treat loss of appetite and poor growth and development caused by lysine deficiency, particularly in infants and children. It is also being investigated for its potential to promote height growth in children with idiopathic short stature when combined with exercise.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on lysine hydrochloride + inositol + vitamin b12.